Physician profile
Robert Matthias
NPI 1770512949
$1,357.80
in general payments reported to CMS, 2019-2025
13 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $787 · 2023: $48.83 · 2024: $374 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $571.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $786.74 | 2020 | |
| Biocomposites INC | $146.53 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $119.65 | 2024-2025 | |
| Depuy Synthes Sales INC. | $57.53 | 2024 | Orthovisc, Monovisc |
| Bioventus LLC | $48.83 | 2023 | Exogen Ultrasound Bone Healing System |
| Endo USA, INC. | $45.77 | 2024-2025 | Xiaflex |
| Si-Bone, INC. | $36.18 | 2024 | |
| Innovation Technologies INC | $33.13 | 2025 | Irrisept |
| Orthofix Medical, INC. | $25.12 | 2025 | Physio-Stim |
| Spr Therapeutics, INC | $23.06 | 2024 | Sprint Pns System |
| Linvatec Corporation | $18.31 | 2024 | Biobrace 23mm |
| Amgen INC. | $16.95 | 2024 | Evenity, Prolia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Matthias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.